Researchers Ma and Kim published a dilution‑and‑delay (DnD) susceptibility assay in Nature Communications that detects previously hidden antibiotic resistance phenotypes at high resolution and throughput. The method uses temporal dilution and growth-delay readouts to unmask resistant subpopulations missed by standard susceptibility tests. The DnD assay increases sensitivity for low-frequency or slow-growing resistant cells and is compatible with scalable workflows, positioning it as a potential tool for both clinical microbiology labs and research screening. The authors validated the method across multiple bacterial strains and antibiotic classes. If adopted, DnD could change how labs identify emergent resistance and guide stewardship decisions; developers and clinical labs will need to assess integration pathways, regulatory validation, and cost-effectiveness for routine use.